Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC)
(Q114738429)
scientific article published on 06 March 2020
scientific article published on 06 March 2020
Language:
other details
| description | scientific article published on 06 March 2020 |
External Links
| (P356) |
10.1200/JCO.2007.25.18_SUPPL.5120
|